Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Thoracoabdominal Aortic Aneurysm Secondary to Aggressive Giant Cell Arteritis.

Bozzani A, Bobbio Pallavicini F, Arici V, Quaretti P, Rossi M, Ticozzelli G, Ragni F.

Ann Vasc Surg. 2020 Jan;62:496.e9-496.e13. doi: 10.1016/j.avsg.2019.06.003. Epub 2019 Aug 5.

PMID:
31394245
2.

Perivascular fibrosis and IgG4-related disease: a case report.

Monti S, Crepaldi G, Peri A, Pietrabissa A, Morbini P, Bobbio-Pallavicini F, Montecucco C, Caporali R.

Reumatismo. 2014 Nov 6;66(3):245-8. doi: 10.4081/reumatismo.2014.753.

3.

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis.

Ferraccioli G, Tolusso B, Bobbio-Pallavicini F, Gremese E, Ravagnani V, Benucci M, Podestà E, Atzeni F, Mannocci A, Biasi D, Manfredi M, Sarzi-Puttini P, Laganà B, Montecucco C.

PLoS One. 2012;7(7):e40362. doi: 10.1371/journal.pone.0040362. Epub 2012 Jul 30.

4.

Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study.

Gremese E, Salaffi F, Bosello SL, Ciapetti A, Bobbio-Pallavicini F, Caporali R, Ferraccioli G.

Ann Rheum Dis. 2013 Jun;72(6):858-62. doi: 10.1136/annrheumdis-2012-201456. Epub 2012 Jul 13.

5.

A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis.

Bazzichi L, Rossi P, Giacomelli C, De Feo F, Bobbio-Pallavicini F, Rossi A, Baldini C, Consensi A, Doveri M, Bonino C, Mazzantini M, Della Rossa A, Montecucco C, Bombardieri S.

Rheumatol Int. 2012 Feb;32(2):349-56. doi: 10.1007/s00296-010-1619-7. Epub 2010 Nov 26.

PMID:
21110028
6.

Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-α blockade with etanercept.

Cavagna L, Sepe V, Bobbio-Pallavicini F, Mangione F, Caporali R, Montecucco C.

Int Urol Nephrol. 2011 Sep;43(3):909-12. doi: 10.1007/s11255-010-9788-6. Epub 2010 Jun 18.

PMID:
20559723
7.

Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases.

Caporali R, Bobbio-Pallavicini F, Atzeni F, Sakellariou G, Caprioli M, Montecucco C, Sarzi-Puttini P.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):749-54. doi: 10.1002/acr.20130.

8.

Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit.

Bassetti M, Righi E, Ansaldi F, Molinari MP, Rebesco B, McDermott JL, Fasce R, Mussap M, Icardi G, Bobbio Pallavicini F, Viscoli C.

J Chemother. 2009 Dec;21(6):633-8.

PMID:
20071286
9.

Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.

Caporali R, Sarzi-Puttini P, Atzeni F, Gorla R, Filippini M, Marchesoni A, Favalli EG, Bobbio-Pallavicini F, Montecucco C.

Autoimmun Rev. 2010 Apr;9(6):465-9. doi: 10.1016/j.autrev.2009.12.010. Epub 2009 Dec 31.

PMID:
20044040
10.

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice.

Marchesoni A, Zaccara E, Gorla R, Bazzani C, Sarzi-Puttini P, Atzeni F, Caporali R, Bobbio-Pallavicini F, Favalli EG.

Ann N Y Acad Sci. 2009 Sep;1173:837-46. doi: 10.1111/j.1749-6632.2009.04621.x.

PMID:
19758236
11.

Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.

Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C.

J Antimicrob Chemother. 2009 Sep;64(3):625-9. doi: 10.1093/jac/dkp251. Epub 2009 Jul 21.

PMID:
19622536
12.

Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C.

JAMA. 2009 Jun 17;301(23):2445-52. doi: 10.1001/jama.2009.856.

PMID:
19531784
13.

Long term treatment of rheumatoid arthritis with rituximab.

Caporali R, Caprioli M, Bobbio-Pallavicini F, Bugatti S, Montecucco C.

Autoimmun Rev. 2009 Jun;8(7):591-4. doi: 10.1016/j.autrev.2009.02.008. Epub 2009 Feb 11.

PMID:
19393205
14.

Diffuse skin reaction after changing the etanercept formulation.

Caporali R, Bobbio-Pallavicini F, Caprioli M, Scorletti E, Montecucco C.

Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1165. No abstract available.

PMID:
19210894
15.

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN).

Sarzi-Puttini P, Antivalle M, Marchesoni A, Favalli EG, Gorla R, Filippini M, Caporali R, Bobbio-Pallavicini F, Montecucco C, Atzeni F.

Reumatismo. 2008 Oct-Dec;60(4):290-5.

16.

Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes.

Bazzani C, Filippini M, Caporali R, Bobbio-Pallavicini F, Favalli EG, Marchesoni A, Atzeni F, Sarzi-Puttini P, Gorla R.

Autoimmun Rev. 2009 Jan;8(3):260-5. doi: 10.1016/j.autrev.2008.11.001. Epub 2008 Nov 21.

PMID:
19027090
17.

DMARDS and infections in rheumatoid arthritis.

Caporali R, Caprioli M, Bobbio-Pallavicini F, Montecucco C.

Autoimmun Rev. 2008 Dec;8(2):139-43. doi: 10.1016/j.autrev.2008.05.001. Epub 2008 Jun 9. Review.

PMID:
19014871
18.

What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?

Bobbio-Pallavicini F, Caporali R, Bugatti S, Montecucco C.

J Rheumatol. 2008 Oct;35(10):1903-5. No abstract available.

PMID:
18843754
19.

Infections and treatment of patients with rheumatic diseases.

Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C, Sulli A, Valesini G, Sarzi-Puttini P.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S67-73. Review.

PMID:
18570757
20.

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.

Atzeni F, Sarzi-Puttini P, Lama N, Bonacci E, Bobbio-Pallavicini F, Montecucco C, Caporali R.

Arthritis Res Ther. 2008;10(3):R51. doi: 10.1186/ar2420. Epub 2008 May 7.

21.

Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center.

Caporali R, Bonacci E, Epis O, Bobbio-Pallavicini F, Morbini P, Montecucco C.

Arthritis Rheum. 2008 May 15;59(5):714-20. doi: 10.1002/art.23579.

22.

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.

Bassetti M, Repetto E, Righi E, Boni S, Diverio M, Molinari MP, Mussap M, Artioli S, Ansaldi F, Durando P, Orengo G, Bobbio Pallavicini F, Viscoli C.

J Antimicrob Chemother. 2008 Feb;61(2):417-20. doi: 10.1093/jac/dkm509. Epub 2008 Jan 3.

PMID:
18174197
23.

Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients.

Cavazzana I, Bobbio-Pallavicini F, Franceschini F, Bazzani C, Ceribelli A, Bravi E, Zingarelli S, Caporali R, Cattaneo R, Montecucco CM.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):676-83.

PMID:
18078613
24.

Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.

Gerli R, Lunardi C, Bocci EB, Bobbio-Pallavicini F, Schillaci G, Caporali R, Bistoni O, Pirro M, Pitzalis C, Montecucco C.

J Rheumatol. 2008 Jan;35(1):14-9. Epub 2007 Dec 1.

PMID:
18061981
25.

Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-alpha treated patients.

Bobbio-Pallavicini F, Caporali R, Alpini C, Moratti R, Montecucco C.

Ann N Y Acad Sci. 2007 Aug;1109:287-95.

PMID:
17785317
26.

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.

Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF; GISEA group.

J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1. Erratum in: J Rheumatol. 2007 Sep;34(9):1947.

PMID:
17611987
27.

[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects].

Cavazzana I, Bobbio-Pallavicini F, Bazzani C, Bravi E, Zingarelli S, Ceribelli A, Caporali R, Cattaneo R, Franceschini F, Montecucco C.

Reumatismo. 2006 Oct-Dec;58(4):275-82. Italian.

28.

Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit (ICU).

Bassetti M, Cruciani M, Righi E, Rebesco B, Fasce R, Costa A, Molinari MP, Mengoli C, Bobbio Pallavicini F, Viscoli C.

J Chemother. 2006 Jun;18(3):261-7.

PMID:
17129836
29.

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Bobbio-Pallavicini F, Caporali R, Alpini C, Avalle S, Epis OM, Klersy C, Montecucco C.

Ann Rheum Dis. 2007 Mar;66(3):302-7. Epub 2006 Nov 1.

30.

BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.

Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Patrizio V, Bobbio-Pallavicini F, Pozzi E, Montecucco C.

Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):111-8.

PMID:
15281432
31.

Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia.

Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Bobbio-Pallavicini F, Pozzi E, Montecucco C.

Ann Rheum Dis. 2004 Jul;63(7):892-4. No abstract available.

32.

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Bobbio-Pallavicini F, Alpini C, Caporali R, Avalle S, Bugatti S, Montecucco C.

Arthritis Res Ther. 2004;6(3):R264-72. Epub 2004 Apr 26.

33.

Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis.

Bardoni A, Rossi P, Salvini R, Bobbio-Pallavicini F, Caporali R, Montecucco C.

Clin Exp Rheumatol. 2003 May-Jun;21(3):301-6.

PMID:
12846047
34.

[Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition]

Bobbio-Pallavicini F, Epis O, Cavagna L, Caporali R, Montecucco C.

Reumatismo. 2001;53(4):312-315. Italian.

35.

Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study.

Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA.

Ann Rheum Dis. 2001 Nov;60(11):1021-4.

36.

Infliximab in the treatment of adult Still's disease refractory to conventional therapy.

Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C.

Clin Exp Rheumatol. 2001 May-Jun;19(3):329-32.

PMID:
11407090
37.

Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease.

Belfiore N, Rossi S, Bobbio-Pallavicini F, Epis O, Caporali R, Montecucco C.

Joint Bone Spine. 2000;67(3):183-7.

PMID:
10875315
38.

'TUNEL' evidence of reduced bone marrow cells apoptosis in a refractory anaemia patient treated with amifostine.

Moroni M, Porta C, Invernizzi R, Inzoli A, Bobbio-Pallavicini F, Bobbio-Pallavicini E.

Br J Haematol. 1999 Feb;104(2):424-5. No abstract available.

PMID:
10050731
39.

[Nutritional support in patients with thoracic trauma: usefulness of an enteral diet with a high fat content].

Bobbio Pallavicini F, Simini G, Zanello M, Verde G, Cassini F, Bichisao G, Braschi A.

Minerva Anestesiol. 1992 Oct;58(10):739-41. Italian. No abstract available.

PMID:
1461448
40.

[Proposal for a protocol of investigation on sleep disorders in patients in resuscitation. Score evaluation in relation to the severity of the case and the degree of sedation of the patient].

Bardellini S, Frattini F, Chiarello E, Mantovani R, Greco P, Bobbio Pallavicini F.

Minerva Anestesiol. 1991 Oct;57(10):901-2. Italian. No abstract available.

PMID:
1961544
41.

[Non-invasive respiration mechanics using the least square fitting in quasi-relaxation during pressure-support ventilation (PSV)].

Palo A, Iotti G, Brunner JX, Braschi A, Rodi G, Bobbio Pallavicini F, Olivei M.

Minerva Anestesiol. 1991 Oct;57(10):858. Italian. No abstract available.

PMID:
1961520
42.

[Relationship of the preceding health status and clinical course in critical surgical patients in intensive care].

Verde G, Bobbio Pallavicini F, Cornara G, Albertario F, Carnevale L, Dionigi RV, Bonizzoni M, Serafini P.

Minerva Anestesiol. 1991 Oct;57(10):814-5. Italian. No abstract available.

PMID:
1961496
43.

[Psychophysical stress in patients admitted to the Intensive Care Department. II: results of a preliminary study].

Maretti D, Gamba A, Aletti M, Bianchi F, Bobbio Pallavicini F, Chiaranda M.

Minerva Anestesiol. 1990 Oct;56(10):1201-3. Italian. No abstract available.

PMID:
2290541
44.

[Psychophysical stress in patients admitted to the Intensive Care Department. I: purpose and method of the study].

Aletti M, Maretti D, Gamba A, Bobbio Pallavicini F, Verona L, Chiaranda M.

Minerva Anestesiol. 1990 Oct;56(10):1197-9. Italian. No abstract available.

PMID:
2290540
45.

[Analysis of 23 years of activity of a polyvalent resuscitation department at a clinical IRCCSS hospital: socioeconomic, ethical and organizational implications on the eve of the year 2000].

Bobbio Pallavicini F, Vitali A, Furione P, Verde G, Emmi V, Ceriana P, Bianchi F, Rossi C, Garofalo M, Bonizzoni M, et al.

Minerva Anestesiol. 1990 Oct;56(10):1189. Italian. No abstract available.

PMID:
2290537
46.

Body iron status in critically ill patients: significance of serum ferritin.

Bobbio-Pallavicini F, Verde G, Spriano P, Losi R, Bosatra MG, Braschi A, Iotti G, Chiaranda M, Villa S.

Intensive Care Med. 1989;15(3):171-8.

PMID:
2738221
47.

[Follow-up of the psychophysical sequelae in critical patients discharged from a multidisciplinary intensive therapy unit].

Bosatra MG, Bobbio Pallavicini F, Verde G, Bausardo MG, Braschi A, Emmi V, Iotti G, Raimondi F, Villa S.

Minerva Anestesiol. 1987 Oct;53(10):571-7. Italian. No abstract available.

PMID:
3452783
48.

[Indications, clinical implications and limitations in the use of a severity of illness index in intensive therapy].

Bobbio Pallavicini F, Bosatra MG, Verde G, Emmi V, Braschi A, Raimondi F, Iotti G, Villa S.

Minerva Anestesiol. 1987 Oct;53(10):565-9. Italian. No abstract available.

PMID:
3133610
49.

Sepsis score and complement factor B for monitoring severely septic surgical patients and for predicting their survival.

Dionigi R, Dominioni L, Jemos V, Cremaschi R, Bobbio-Pallavicini F, Ballabio A.

Eur Surg Res. 1985;17(5):269-80.

PMID:
3850809
50.

[Short bowel syndrome. Conservative treatment of a case in pediatric age].

Manzoni GA, Balossi P, Heinen M, Bobbio-Pallavicini F.

Minerva Pediatr. 1983 Nov 15;35(21):1069-72. Italian. No abstract available.

PMID:
6423944

Supplemental Content

Loading ...
Support Center